Lidocaine topical for Cluster Headache

"At the moment, there are 139 clinical trials researching the efficacy of Lidocaine topical. 36 of those trials are in the third and final stage. The majority of these studies are based in Calgary, Alberta; however, there are 1105 locations running these sorts of trials."

"Lidocaine topical scored a 3 for safety. This is due to the fact that it is a Phase 3 trial, which suggests that not only is there some evidence of efficacy, but also that there have been multiple rounds of data collected to support its safety."

"The age limit for participants in this clinical trial is between 10 and 20 years old."

"This particular clinical trial is seeking to enrol 72 adolescents between the ages of 10 and 20 who suffer from sphenopalatine neuralgia. In order to be eligible, participants must also meet the following: - Frontal migraine headache."

"This is accurate. The clinical trial is admitting 72 participants between 1 sites."

"The information available on clinicaltrials.gov supports that this trial is currently looking for participants. This study was first posted on 2019-06-06 and was most recently edited on 2021-11-16. 72 patients need to be enrolled from 1 location."

"The purpose of this trial, which will last for up to 6 hours after participants are discharged, is to study the time it takes for headaches to resolve. Additionally, the trial will also monitor for side effects that occur within 24 hours of the intervention, patient satisfaction, and whether or not the headache persists after 24 hours."

"Lidocaine topical is most frequently used as a treatment for cervical syndrome. However, it has also been shown to ameliorate symptoms related to minor burns, transplantation, and osteoporosis."